833-CELLERO
Everything You Need to Investigate the COVID-19 Immune Response As the world continues to grapple with the coronavirus pandemic, researchers like you are working double-time to develop new COVID-19 vaccines and treatments. Our scientists have recently deployed multiple SARS-CoV-2 related products to aid in the research and development of life-saving discoveries. Your Go-To…
In addition to our mobilized CD34+ stem cells collected from peripheral blood, we now offer two new types of human hematopoietic stem cells derived from their natural habitat: bone marrow! 1) Bone Marrow CD34+ Stem Cells These versatile immune cells give rise to all hematopoietic cell types — from platelets to mononuclear cells to granulocytes…
We have some big news to share, and we’re glad you’re here to read about it! Today, Cellero has announced that we will officially be joining Charles River. This exciting change will complement Charles River’s recent acquisition of HemaCare and allow our company to better serve a growing list of customers and partners across the…
Convalescent COVID-19 T-cells, PBMC and Plasma Now Available LOWELL, MA – July 28, 2020 – Cellero, the leading provider of donor and patient collection services, GMP-grade biomaterials, characterized immune cells, and custom research services, today announced the launch of new convalescent COVID-19 blood products to support research and vaccine development. Blood products collected from convalescent…
Plasma from convalescent COVID-19 patients has been all over the news as a proposed treatment for coronavirus, with the hope that antibodies in the plasma can neutralize the virus and prevent entry into cells. While studies into the safety and effectiveness of this treatment approach are ongoing, convalescent plasma is also needed to drive research…
Human PBMC hold a vast amount of untapped information relevant to immunology, toxicology, inflammation, vaccination, and other areas of study related to the human immune response. We’ve added to our growing list of disease-state PBMC with products collected from donors with a history of SARS-CoV-2 infection, the novel coronavirus. Peripheral Blood Mononuclear Cells from…
Our scientists have been working hard to develop an antigen-specific T cell line directed against the spike protein of SARS-CoV-2, the virus that causes COVID-19. The line is now available on our website for purchase. Preliminary studies, such as this one in Cell, suggest a T cell defense against COVID-19 found in infected individuals and…
If you haven’t noticed already, our collection of antigen-specific T cells is growing quickly, specifically in the family of autoimmune diseases! Our current available inventory includes T cells that are specific for antigens believed to be responsible for tissue damage in multiple sclerosis, diabetes, and vitiligo. Learn how you can apply these unique cells to…
Biopharma, biotech, and academic researchers are on the front lines of discovering treatments and cures to the world’s most complicated diseases and widespread public health threats. Now more than ever — as you begin to return to the lab — we are here to support you in your relentless pursuit of cures. Tap into our…
With so many commercial characterized immune cell, leukapheresis, and apheresis products available in one place, it can be difficult to determine the best fit for your research and development needs. The big decisions immune cell and biomaterial buyers face comes down to two factors: Fresh or frozen product? By the vial or full leukopak? This…